Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis

BACKGROUND: Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group of medications has not been quantified. Our objective was to quantitatively summarize data on the e...

Descrición completa

Detalles Bibliográficos

Publicado en:	CMAJ
Principais autores:	Lanctôt, Krista L., Herrmann, Nathan, Yau, Kenneth K., Khan, Lyla R., Liu, Barbara A., LouLou, Maysoon M., Einarson, Thomas R.
Formato:	Artigo
Idioma:	Inglês
Publicado:	Canadian Medical Association 2003
Assuntos:	Research
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12975222/
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!